Tillo, Rosario M.
HRN: 03-23-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/27/2026
07/04/2026
IV
4.5g
Q8hrs ANST
CAP Vs HAP
Checking Initial Appropriateness
Indication: Empirical Escalation Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines